About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Sequential Coronary CT-angiography and Biomarkers | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT02394262

Sequential Coronary CT-angiography and Biomarkers

Currently, cardiac computed tomography angiography (CCTA) is a well-implemented non-invasive diagnostic imaging modality in patients with stable chest pain. Besides conventional CT-reading, CCTA is al...

Lead sponsor: Maastricht University Medical Center•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Bas Kietselaer, MD, PhD

CONTACT

+31433871587 [email protected]

Sibel Altintas, MD

CONTACT

+31433881232 [email protected]

Sponsors

Lead Sponsor

Maastricht University Medical Center

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with a recent history of (a)typical chest pain, who underwent a coronary calcium score scan as well as CCTA.
•Age older than 18 years and competent to perform written informed consent.
•At least 2 coronary segments with plaques:
•1 proximal lesion.
•At least one coronary plaque consisting of a non-calcified or mixed component.

Exclusion Criteria

•Unstable angina.
•Renal insufficiency: calculated estimated glomerular filtration rate \<45mL/min.
•Iodine allergy.
•Pregnancy.
•Known history of atrial fibrillation.
•Inconclusive baseline computed coronary CT-angiography.
•Patients which are currently on oral vitamin K antagonists.
•Patients which are currently using selective anticoagulants.
•Previous PCI.
•Previous or planned coronary artery bypass grafting.
•Patients whereby the baseline CCTA was performed by a retrospective ECG-gated 'helical' protocol due to a high (\>90bpm) or irregular heart rate.

Related studies

Effect of Mobile-Based Home Cardiac Rehabilitation on Coronary Plaque

NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis

RECRUITINGPhase 3

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more

Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History

NCT05867381 · Air Pollution, Atherosclerosis

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT06779630 · Coronary Artery Disease

Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry

NCT07565805 · Coronary Artery Disease (CAD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 28, 2017Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment140

Start dateMar 2015

Last updatedMar 28, 2017

Condition

Coronary Artery Disease Atherosclerosis

Locations shown

Maastricht University Medical Center

Maastricht, Limburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 28, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions